Novo Nordisk | chemanager-online.com - Chemistry and Life Science

Feb. 12, 2020
News & Opinions
Novo Nordisk to Upgrade Danish Insulin Plant
Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s output accounts for about half the world’s output ...
Jan. 29, 2020
News & Opinions
AstraZeneca Aims to be Carbon Neutral by 2025
Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon emissions from its global operations by 2025.
Apr. 11, 2019
News & Opinions
Novo Nordisk Upgrades Danish Plant
Danish drugmaker Novo Nordisk plans to invest 650 million krone, or $98 million, to upgrade and expand facilities at its site in Kalundborg. ...
Mar. 15, 2019
News & Opinions
Novo Nordisk Launches innovation Platform in China
Under the name INNOVO, Danish diabetes giant Novo Nordisk has launched an innovation platform for China in a drive to accelerate the transformation of scientific research into new drugs or improve older drugs by strengthening ...
Jan. 16, 2019
News & Opinions
Novo Nordisk Pharmatech and DKSH in Distribution Pact
Denmark’s Novo Nordisk Pharmatech has partnered with the Performance Materials business unit of DKSH, a major ingredients and specialty chemicals distributor specializing in Asia, to distribute the Danish company’s ...
Nov. 30, 2018
Topics
Opportunities for Western CDMOs in China
As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent years driven by targeted and developing policies. Over the ...
Sep. 13, 2018
News & Opinions
Ossianix and Novo Nordisk link on BBB Research
Ossianix, a privately held US pharmaceutical research firm based in Philadelphia, Pennsylvania, has entered a research collaboration and option agreement with Danish drugmaker Novo Nordisk to deliver therapeutic molecules in diabetes and ...
Aug. 27, 2018
News & Opinions
Novo Nordisk Buys Ziylo Spin-out
Danish pharma Novo Nordisk is boosting its efforts to develop the world’s first glucose responsive insulin and transform the treatment of diabetes following its purchase of Ziylo, a spin-out from the UK’s University of Bristol. ...
Jun. 25, 2018
News & Opinions
Novo Nordisk and Kallyope in Gut-Brain Pact
Danish drugmaker Novo Nordisk is collaborating with Kallyope, a US biotech focused on the gut-brain axis, to discover novel peptide therapeutics for obesity and diabetes. Kallyope has developed a platform to interrogate the gut-brain axis, ...
Jun. 11, 2018
News & Opinions
Novo Nordisk said to plan Major Layoffs
Drugmaker Novo Nordisk plans to cut as many as 3,000 jobs and may reduce its financial guidance, according to a report in the Danish financial newspaper Borsen. The paper, citing unnamed sources with knowledge of the process, said the ...

12 3 4 5 6

Register now!

The latest information directly via newsletter.

GIT Verlag